2023
Peripheral Blasts in a Patient Receiving Chemotherapy
Kshattry S, Parker T, Huntington S. Peripheral Blasts in a Patient Receiving Chemotherapy. JAMA 2023, 330: 1581-1582. PMID: 37801303, DOI: 10.1001/jama.2023.17117.Peer-Reviewed Original Research
2022
Hyperferritinemia as predictive biomarker of poor clinical outcomes in CMML.
Aguirre L, Ball S, Jain A, Al Ali N, Sallman D, Kuykendall A, Sweet K, Lancet J, Padron E, Komrokji R. Hyperferritinemia as predictive biomarker of poor clinical outcomes in CMML. Journal Of Clinical Oncology 2022, 40: 7055-7055. DOI: 10.1200/jco.2022.40.16_suppl.7055.Peer-Reviewed Original ResearchAML transformationTransfusion dependenceFerritin levelsBiomarker of poor clinical outcomeMultivariate analysisRisk of myeloid malignanciesAssociated with more aggressive diseaseBiomarkers of disease activityHigh-risk diseasePoor clinical outcomesRisk of poor outcomesHistory of infectionMoffitt Cancer CenterAssociated with inflammationIPSS-RPeripheral blastsAnalysis of gene signaturesCMML-2Myeloid malignanciesEstimate OSAggressive diseaseRisk diseaseMedian ageDismal outcomeHigher ferritin
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply